An Exploratory, Multi-Centre, Interventional, Prospective, Randomised, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of AON-D21 in Patients with Severe Community-Acquired Pneumonia.
This important study is looking into a new medicine, called AON-D21, for people who have severe pneumonia they caught in the community. It's a 'Phase II' study, which means it's still in the early stages of testing, after initial safety checks. The main goal is to find out how safe AON-D21 is and if it causes any side effects, both serious and minor. To do this, some patients will receive AON-D21, while others will get a placebo (a dummy treatment that looks the same but contains no active medicine). This comparison helps researchers understand the medicine's true effects. They will also look at how quickly people recover, for example, if they need less breathing support, and how the medicine moves through the body.
At a glance
What is this study about?
Severe pneumonia is a serious lung infection that can make breathing very difficult and sometimes requires intensive care. This particular study is investigating a new potential medicine, AON-D21, for adults who have been diagnosed with this condition. The study is called a 'randomised, double-blind, placebo-controlled clinical trial'. This means that participants are randomly assigned to one of two groups: one group receives the active medicine (AON-D21), and the other group receives a placebo. A placebo looks exactly like the real medicine but contains no active ingredients – in this case, it's a simple sugar solution. Neither the patients nor their doctors will know who is getting which treatment, which helps to ensure the results are as fair and unbiased as possible. This approach is the gold standard for testing new medicines.
The main purpose of this study is to carefully monitor the safety of AON-D21. Researchers will be looking closely at any side effects people experience, how severe they are, and whether they seem to be related to the study medicine. This is crucial for understanding if AON-D21 is well-tolerated by patients with severe pneumonia. Beyond safety, the study also aims to see how effective AON-D21 might be. Researchers will measure things like how quickly patients no longer need breathing support, how long it takes for them to improve, and how the medicine affects their overall recovery.
Understanding how a new medicine works and if it's safe is a long process, and studies like this are a vital step. The information gathered will help doctors and scientists decide if AON-D21 could be a helpful treatment option for severe pneumonia in the future. It's important to remember that this is an exploratory study, meaning it's designed to gather initial information rather than providing definitive answers right away.
Key takeaways
- This study is testing a new medicine, AON-D21, for severe pneumonia.
- The main goals are to check the medicine's safety and effectiveness.
- Some patients will get the real medicine, others a dummy treatment (placebo).
- You won't know if you're getting the medicine or the placebo.
- Your health will be closely monitored for at least 28 days.
- Participation is entirely voluntary, and you can withdraw at any time.
Who may be eligible?
To be considered for this study, you need to be at least 18 years old. There is no upper age limit, meaning older adults can also take part. The study is open to both men and women.
Crucially, you must have been diagnosed with severe pneumonia that you caught outside of a hospital setting. The study will have specific medical criteria that your doctors will check to make sure the medicine is suitable for you and that you fit the study's requirements.
Your medical team will review your health information to confirm if you meet all the necessary conditions to join. They will explain everything in detail if they think you might be suitable.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you recently been diagnosed with severe pneumonia that you caught outside of hospital?
- Are you able to understand and consider the information about the study?
- Are you currently in a hospital setting where this study is being conducted?
What does participation involve?
If you decide to take part, you would receive the study medicine (or placebo) through a drip into your arm. You would be closely monitored by the study doctors and nurses, likely while you are in the hospital. They would conduct various assessments to check your health, how you're responding to treatment, and any side effects you might experience. These assessments would involve regular checks of your breathing, vital signs, and possibly blood tests.
The study will follow your progress for at least 28 days from when you start treatment, looking at your recovery and any side effects. Some assessments, like checking on your overall survival, might continue up to 60 days. The doctor will explain the exact schedule of visits and tests you would need. You will have a clear point of contact for any questions or concerns you have throughout the study.
Potential risks and benefits
Locations (4)
- —UnverifiedBelgium
- —UnverifiedFrance
- —UnverifiedGermany
- —UnverifiedSpain
Common questions
What is 'severe community-acquired pneumonia'?
It's a serious lung infection that you get outside of a hospital setting, which is making you very unwell and often requires hospital treatment.
What is a placebo?
A placebo is a 'dummy' treatment that looks just like the real medicine but contains no active drug. It helps researchers compare the new medicine's effects accurately.
What does 'double-blind' mean?
It means neither you nor your doctor will know if you are receiving the real medicine (AON-D21) or the placebo. This helps make the study fair.
How long will I be involved in the study?
You'll be closely monitored for at least 28 days after starting treatment, and your overall health might be checked up to 60 days later. Your doctors will tell you the exact schedule.
Can I stop participating in the study if I change my mind?
Yes, absolutely. You can withdraw from the study at any point, and it will not affect the care you receive from your doctors.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.